PSNL

Personalis, Inc.

A cancer genomics company that reads the full DNA of a patient's tumor to help doctors spot cancer returning earlier than scans can. Its flagship test, NeXT Personal, is a liquid biopsy that hunts for tiny traces of tumor DNA in a blood sample. Founded in 2011 by Stanford University researchers, the company's name comes from "personalized" medicine — tailoring cancer care to each patient's unique genetic makeup.

CUSIP: 71535D106HealthcareUS2 holders

Ownership Activity Financials Filings

PSNL

PSNL

Other Events

Results of Operations and Financial Condition

Results of Operations and Financial Condition

Entry into a Material Definitive Agreement

Other Events

Other Events

Submission of Matters to a Vote of Security Holders

Results of Operations and Financial Condition